CLONAL AMPLIFICATION OF NUCLEIC ACID ON SOLID SURFACE WITH TEMPLATE WALKING

• US 20170067098A1
• Filed: 09/26/2016
• Published: 03/09/2017
• Est. Priority Date: 12/17/2010
• Status: Active Grant

• Current Assignee: Life Technologies Corporation (Thermo Fisher Scientific Incorporated)
• Original Assignee: Life Technologies Corporation (Thermo Fisher Scientific Incorporated)
• Inventors: KUNKEL, Jennifer, KASINSKAS, Rachel, LI, Bin, LAO, Kai Qin, O'NEIL, Jennifer, HALEY, Kellie, MA, Zhaochun, BRZOSKA, Pius
• Granted Patent: US 10,233,488 B2
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: C12P 19/34 Polynucleotides, e.g. nucleic acids, oligoribonucleotides
• CPC Class Codes: C12Q 1/46 involving cholinesterase
• CPC Class Codes: C12Q 1/6806 Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/6834 Enzymatic or biochemical coupling of nucleic acids to a solid phase
• CPC Class Codes: C12Q 1/6846 Common amplification features
• CPC Class Codes: C12Q 1/6853 using modified primers or templates
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 1/6874 involving nucleic acid arrays, e.g. sequencing by hybridisation
• CPC Class Codes: C12Q 2521/507 Recombinase
• CPC Class Codes: C12Q 2527/101 Temperature
• CPC Class Codes: C12Q 2531/119 Strand displacement amplification [SDA]
• CPC Class Codes: C12Q 2537/1376 Displacement by an enzyme
• CPC Class Codes: C12Q 2565/537 characterised by the capture oligonucleotide acting as a primer

Abstract

Novel methods of generating a localized population of immobilized clonal amplicons on a support are provided.

Claims

1. A method for amplifying a plurality of nucleic acid templates, comprising:

a) providing a plurality of forward primers immobilized on a support, wherein the plurality of forward primers includes a first forward primer and a second forward primer, wherein the plurality of forward primers have substantially identical sequences;

b) providing a nucleic acid reverse strand from the plurality of nucleic acid templates, wherein the nucleic acid reverse strand includes a forward primer-binding sequence that can hybridize to any one of the plurality of forward primers;

c) hybridizing the first forward primer to the forward primer-binding sequence on the nucleic acid reverse strand;

d) generating an extended forward strand that is substantially complementary to the nucleic acid reverse strand and is hybridize thereto, by primer extension of the first forward primer using the reverse strand as a template;

e) partially denaturing the first forward primer and the forward primer-binding sequence on the nucleic acid reverse strand and hybridizing the second forward primer to the forward primer-binding sequence on the nucleic acid reverse strand, wherein a portion of the nucleic acid reverse strand is also hybridized to the extended forward strand;

f) generating another extended forward strand that is substantially complementary to the nucleic acid reverse strand and is hybridized thereto, by primer extension of the second forward primer using the reverse strand as a template; and

g) amplifying the plurality of nucleic acid templates simultaneously in a single continuous liquid phase without first compartmentalizing, by performing one or more amplification cycles comprising steps (e)-(f) under isothermal conditions to form clonal nucleic acid populations, wherein the second forward primer of step (e) of an amplification cycle acts as the first forward primer of step (e) of a subsequent amplification cycle;

wherein the amplifying is carried out by adjusting the isothermal conditions to a temperature that is higher than the T_m of all forward primers, but lower than the T_m of the reverse strands;

and wherein the partial denaturation in step (e) is achieved by (i) using a recombinase, or (ii) using a single strand binding protein.

2. The method of claim 1, wherein the support comprises only primers having sequences that are substantially identical to the plurality of forward primers.

3. The method of claim 1, wherein step (e) comprises:

fully denaturing the forward primer-binding sequence on the nucleic acid reverse strand from the extended forward strand and hybridizing the-forward primer-binding sequence to the second forward primer.

4. The method of claim 1, wherein at least 60% of the bases of the plurality of forward primers are adenine, thymine or uracil, or are complementary to adenine, thymine or uracil.

5. The method of claim 1, wherein primer extension of the second forward primer using the reverse strand as a template results in displacing the extended forward strand that is hybridized to the nucleic acid reverse strand.

6. The method of claim 1, further comprising:

hybridizing the forward primer-binding sequence on the nucleic acid reverse strand to a third forward primer immobilized to the support, wherein a portion of the reverse strand is also hybridized to an extended forward strand, and wherein the third forward primer includes a sequence that is substantially identical to the plurality of forward primers sequences.

7. The method of claim 6, wherein the hybridizing the forward primer-binding sequence on the nucleic acid reverse strand to a third forward primer comprises:

fully denaturing the forward primer-binding sequence on the nucleic acid reverse strand from the extended other forward strand and re-hybridizing the fully denatured forward primer-binding sequence to the third forward primer.

8. The method of claim 7, further comprising:

generating another extended forward strand that is a full-length complement of the reverse strand and is hybridized thereto, by primer extension of the third forward primer using the reverse strand as a template.

9. The method of claim 5, further comprising:

a) hybridizing a first reverse primer to a reverse primer-binding sequence on the extended forward strand, by denaturing the reverse primer-binding sequence on the extended forward strand from the nucleic acid reverse strand, wherein the first reverse primer is a soluble primer;

b) extending the first reverse primer using the extended forward strand as a template; and

c) generating an extended reverse strand that is substantially-complementary to the forward strand and hybridized thereto.

10. The method of claim 1, wherein the amplifying is carried out by adjusting the isothermal conditions to a temperature range between 45°

C. and 80°

C.

11. The method of claim 1, wherein the plurality of forward primers are immobilized adjacent to each other in a continuous lawn on the support.

12. The method of claim 1, wherein the forward primers are immobilized on the support at a plurality of spatially-separate immobilization sites.

13. The method of claim 1, wherein the plurality of nucleic acid templates is produced by taking a plurality of input nucleic acid sequences and appending a first universal adaptor sequence onto the ends of at least one input nucleic acid, and wherein the first universal adaptor sequence hybridizes to the immobilized forward primers.

14. The method of claim 13, wherein the individual clonal nucleic acid populations are immobilized within or on a different support from other amplified populations.

15. The method of claim 9, further comprising subjecting the amplified forward strands and the amplified reverse strands to a sequencing reaction.

16. The method of claim 10, wherein at least 50% of reverse strands are hybridized to forward strands at all times during the amplifying.

17. The method of claim 10, wherein the amplifying is carried out using a polymerase that is active at a temperature at or above 45°

C.

18. The method of claim 17, wherein the amplifying is carried out by maintaining the temperature at a range of between 45°

C. and 70°

C.

19. The method of claim 17, wherein the amplifying is carried out by maintaining the temperature at or around 50°

C., 55°

C., 60°

C., 65°

C., or 70°

C. for between 10 and 120 minutes.